NYSE:CNC - Centene Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $56.04 +0.47 (+0.85 %) (As of 05/19/2019 02:18 AM ET)Previous Close$56.04Today's Range$54.81 - $56.5352-Week Range$45.44 - $74.49Volume11.76 million shsAverage Volume10.92 million shsMarket Capitalization$23.15 billionP/E Ratio15.83Dividend YieldN/ABeta1.21 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions, limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. Its Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri. Receive CNC News and Ratings via Email Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Hospital & medical service plans Sub-IndustryManaged Health Care SectorMedical Current SymbolNYSE:CNC Previous Symbol CUSIP15135B10 CIK1071739 Webwww.centene.com Phone314-725-4477Debt Debt-to-Equity Ratio0.58 Current Ratio1.04 Quick Ratio1.04Price-To-Earnings Trailing P/E Ratio15.83 Forward P/E Ratio12.85 P/E Growth0.94 Sales & Book Value Annual Sales$60.12 billion Price / Sales0.39 Cash Flow$4.6817 per share Price / Cash Flow11.97 Book Value$28.16 per share Price / Book1.99Profitability EPS (Most Recent Fiscal Year)$3.54 Net Income$900 million Net Margins1.66% Return on Equity14.60% Return on Assets5.18%Miscellaneous Employees47,300 Outstanding Shares413,180,000Market Cap$23.15 billion Next Earnings Date7/23/2019 (Estimated) OptionableOptionable Centene (NYSE:CNC) Frequently Asked Questions What is Centene's stock symbol? Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC." When did Centene's stock split? How did Centene's stock split work? Centene's stock split before market open on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly issued shares were payable to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split. How were Centene's earnings last quarter? Centene Corp (NYSE:CNC) posted its earnings results on Tuesday, April, 23rd. The company reported $1.39 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.32 by $0.07. The firm earned $18.44 billion during the quarter, compared to analyst estimates of $17.44 billion. Centene had a return on equity of 14.60% and a net margin of 1.66%. The business's revenue was up 39.8% compared to the same quarter last year. During the same period last year, the business posted $2.17 earnings per share. View Centene's Earnings History. When is Centene's next earnings date? Centene is scheduled to release their next quarterly earnings announcement on Tuesday, July 23rd 2019. View Earnings Estimates for Centene. How can I listen to Centene's earnings call? Centene will be holding an earnings conference call on Tuesday, July 23rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link. What guidance has Centene issued on next quarter's earnings? Centene issued an update on its FY19 earnings guidance on Tuesday, April, 23rd. The company provided earnings per share guidance of $4.24-4.44 for the period, compared to the Thomson Reuters consensus estimate of $4.25. The company issued revenue guidance of $72.8-73.6 billion, compared to the consensus revenue estimate of $70.76 billion.Centene also updated its FY 2019 guidance to $4.24-4.44 EPS. What price target have analysts set for CNC? 18 brokers have issued 1 year target prices for Centene's shares. Their predictions range from $63.00 to $85.00. On average, they expect Centene's stock price to reach $76.5213 in the next year. This suggests a possible upside of 36.5% from the stock's current price. View Analyst Price Targets for Centene. What is the consensus analysts' recommendation for Centene? 18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene. What are Wall Street analysts saying about Centene stock? Here are some recent quotes from research analysts about Centene stock: 1. According to Zacks Investment Research, "Centene’s first-quarter 2019 adjusted earnings per share of $1.39, beat the Zacks Consensus Estimate by 5.3% and also improved 27.5% year over year on the back of Fidelis buyout, growing revenues, etc. Its shares have outperformed its industry quarter to date. Its momentum in revenue growth is likely to grow on the back of rising membership and expansion. The company boasts an impressive inorganic growth strategy, driven by buyouts. It recently entered into an agreement with WellCare, which will position the company as the largest Medicaid managed care organization in the country. Medical membership of the company has been rising over the past several quarters owing to contract wins. However, mounting operating costs remain a headwind. In 2019, adjusted SG&A expense ratio is estimated between 9.3% and 9.8%. Also, high debt level increases leverage risk." (5/17/2019) 2. Cantor Fitzgerald analysts commented, "We rate Centene Corporation (CNC) DCF-based price target of $145 per share. We continue to view Medicaid as a good growth opportunity. At the same time, CNC is building its Medicare Advantage business, increasing its footprint in individual exchange markets (and doing it profitably) and increasing its specialty offerings. $145 per share 12-month price target is based on DCF analysis." (12/13/2018) Has Centene been receiving favorable news coverage? Media stories about CNC stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Centene earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. Who are some of Centene's key competitors? Some companies that are related to Centene include Aetna (AET), Anthem (ANTM), Cigna (CI), Humana (HUM), WellCare Health Plans (WCG), Molina Healthcare (MOH), Trupanion (TRUP) and Advanzeon Solutions (CHCR). What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some companies that other Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Visa (v), Adobe (ADBE), Micron Technology (MU), Netflix (NFLX), Home Depot (HD), Boeing (BA) and Mastercard (MA). Who are Centene's key executives? Centene's management team includes the folowing people: Mr. Michael Frederic Neidorff, Chairman, Pres & CEO (Age 76)Mr. Jeffrey Alan Schwaneke C.P.A., CPA, Exec. VP, CFO & Treasurer (Age 43)Ms. Brandy Lynn Burkhalter, Exec. VP of Operations (Age 46)Mr. Mark J. Brooks, Exec. VP & Chief Information Officer (Age 49)Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 43) Who are Centene's major shareholders? Centene's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.84%), Geode Capital Management LLC (1.46%), AQR Capital Management LLC (1.33%), Northern Trust Corp (1.14%), FMR LLC (1.13%) and Janus Henderson Group PLC (1.13%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene. Which major investors are selling Centene stock? CNC stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Altshuler Shaham Ltd, Teacher Retirement System of Texas, Carillon Tower Advisers Inc., CIBC Private Wealth Group LLC, Lazard Asset Management LLC, Avalon Advisors LLC and Renaissance Technologies LLC. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Keith H Williamson, Mark J Brooks and Robert K Ditmore. View Insider Buying and Selling for Centene. Which major investors are buying Centene stock? CNC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Viking Global Investors LP, Geode Capital Management LLC, AQR Capital Management LLC, Janus Henderson Group PLC, Northern Trust Corp, Eminence Capital LP and FMR LLC. View Insider Buying and Selling for Centene. How do I buy shares of Centene? Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Centene's stock price today? One share of CNC stock can currently be purchased for approximately $56.04. How big of a company is Centene? Centene has a market capitalization of $23.15 billion and generates $60.12 billion in revenue each year. The company earns $900 million in net income (profit) each year or $3.54 on an earnings per share basis. Centene employs 47,300 workers across the globe. What is Centene's official website? The official website for Centene is http://www.centene.com. How can I contact Centene? Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected] MarketBeat Community Rating for Centene (NYSE CNC)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 820 (Thanks for Voting!)Underperform Votes: 538 (Thanks for Voting!)Total Votes: 1,358MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: What is a put option? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.